HALO logo
halo search icon
Lucid Diagnostics Inc.
Lucid Diagnostics Inc.
LUCD · NAS

Lucid Diagnostics Inc.

US$1.00

Price Arrow0.053 (5.60%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEngulfing BullishHALO AllHALO Capital EfficiencyHALO Consensus ValueHALO GrowthNear 52 Week Low+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Lucid Diagnostics Inc. Overview

LUCD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About LUCD

icon

Website

Lucid Diagnostics Inc.

icon

Telephone

1.917.813.1828

icon

Address

25th Floor, 360 Madison Avenue, New York, NY 10017

Description

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

LUCD Price Chart

Key Stats

Market Cap

US$192.30M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.94 - 1.7

Trade Value (12mth)

US$325,402.00

1 week

-4.45%

1 month

-26.02%

YTD

-15.45%

1 year

-28.8%

All time high

13.52

Key Fundamentals

EPS 3 yr Growth

-55.40%

EBITDA Margin

NaN%

Operating Cashflow

-$46m

Free Cash Flow Return

-487.90%

ROIC

-608.90%

Interest Coverage

NaN

Quick Ratio

1.30

Other Data

Shares Outstanding (Fully Diluted)

140m

HALO Sector

Healthcare

Next Company Report Date

29-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LUCD Announcements

Latest Announcements

DateAnnouncements
19 May 26
14 May 26
14 May 26
14 May 26
14 May 26

LUCD Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.26-1.05-0.69locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.26-1.05-0.69locklocklock
Growth
%locklocklocklock18.816.834.1locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Lucid Diagnostics Inc. (LUCD:NAS)?
Halo FAQ
The current share price of Lucid Diagnostics Inc. (LUCD:NAS) is USD$1.00.
What is the 52-week high share price for Lucid Diagnostics Inc. (LUCD:NAS)?
Halo FAQ
The 52-week high share price for Lucid Diagnostics Inc. (LUCD:NAS) is USD$1.70.
What is the 52-week low share price for Lucid Diagnostics Inc. (LUCD:NAS)?
Halo FAQ
The 52-week low share price for Lucid Diagnostics Inc. (LUCD:NAS) is USD$0.94.
What is the dividend yield for Lucid Diagnostics Inc. (LUCD:NAS)?
Halo FAQ
Lucid Diagnostics Inc. (LUCD:NAS) does not pay a dividend.
What was Lucid Diagnostics Inc. (LUCD:NAS) last dividend payment?
Halo FAQ
Lucid Diagnostics Inc. (LUCD:NAS) does not pay a dividend.
What is the franking level for Lucid Diagnostics Inc. (LUCD:NAS)?
Halo FAQ
Lucid Diagnostics Inc. (LUCD:NAS) has a franking level of 0.00%.
In which sector is Lucid Diagnostics Inc. (LUCD:NAS) classified?
Halo FAQ
Lucid Diagnostics Inc. (LUCD:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.